Antibiotic susceptibility testing market revenue totaled USD 2.82 Billion in 2021. The global market is expected to reach a valuation of USD 4.05 Billion by 2028, expanding at a CAGR of 5.2%.
| Antibiotic Susceptibility Testing Market Size (2022) | USD 3 Billion |
|---|---|
| Sales Forecast (2028) | USD 4.05 Billion |
| Global Market Growth Rate (2022 to 2028) | 5.2% CAGR |
| Share of Top 5 Market Players | 50% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1, 2021 | 5.64% |
| H1, 2022 Projected | 5.16% |
| H1, 2022 Outlook | 4.66% |
| BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 50 ↓ |
| BPS Change - H1, 2022 (O) - H1, 2021 | (-) 98 ↓ |
The global antibiotic susceptibility testing market is subject to changes as per the macro and industrial dynamics associated with the drug and device regulations, product licensing, and product distribution.
Key developments in the market include the development of novel MALDI-TOF mass spectrometry for the rapid identification of disease pathogens or causative bacterial organisms.
H1-2022 outlook period in comparison to H1-2022 projected period showed a negative growth in terms of Basis Point Share by 50 BPS. However, In H1-2022, the market growth rate of antibiotic susceptibility testing is expected to fall by 98 basis point share (BPS), as per FMI analysis.
The drop in the BPS values is associated with the complicated pre-analytical process associated with antibiotic susceptibility testing thus presenting a high procedural cost. Moreover, the necessity for a comparatively vast quantity of viable organisms, and a limited database spectrum for micro-organisms has presented a hurdle in the growth of the market, thus resulting in the reduced BPS values.
However, the expected introduction of microfluidics and microdroplets for antibiotic susceptibility testing will present a positive growth outlook for the market over the forecasted years.
Increasing Awareness Initiatives about Antibiotic Resistance to Boost Demand for Antibiotic Susceptibility Testing
From 2013 to 2021, the global antibiotic susceptibility testing market progressed at a CAGR of around 5.5%.
Antibiotic susceptibility testing is performed as a routine to ensure the efficient use of antibiotics. It determines the lowest concentrations of new or existing antimicrobial agents and inhibits consistent and visible growth of the bacterium that is being investigated, under specific test conditions.
It is the detection of possible drug resistance in some of the most common pathogens and the discovery of susceptibility of the drugs of choice for particular infections.
Constant advancements in instruments used for antibiotic susceptibility testing have led to gaining FDA clearance for these systems.
Modifications in antibiotic susceptibility testing instruments include improvements in the computer software for either providing an extended incubation period for difficult organism-drug combinations or, by using expert software to edit susceptibility test results for prevention of unwanted results from being noted.
The global antibiotic susceptibility testing market is anticipated to expand at a 5.2% CAGR from 2022 to 2028.
Principal Consultant
Advancements in Rapid AST Methods & Instruments to Fuel Market Expansion
Rapid AST methods enable targeted therapy for any treatment, as early as possible. Growing advancements in AST methods are expected to boost the market growth for antibiotic susceptibility testing during the forecast period.
Widespread usage of online channels is responsible for a consistent and rapid increase in the sales of antibiotic susceptibility testing systems in recent years. Vendors operating in the antibiotic susceptibility testing market are focusing on online marketing and promotional strategies to increase sales and ensure better access to their devices.
Online platforms enable vendors to offer information about the devices in their portfolios as well as gain access to local as well as global markets. In addition, online marketing websites offer a wide selection of branded AST methods at affordable costs and attractive discounts.
Complex Regulatory Framework Major Restraining Factor for Market Growth
Automated antibiotic susceptibility testing tools are costly as they come with several complex features and functions. Incubation and detection times are cut by 50% when automated AST methods are resorted to. This factor is a major hurdle to their widespread acceptance by end users, particularly smaller medical facilities.
Furthermore, scientific and regulatory challenges faced by businesses in the market extend the time to market and raise development costs, thereby compromising product marketability. The market is likely to be restrained by tight regulatory government policies and the hurdles involved with antimicrobial susceptibility testing.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Ongoing Advancements in Antibiotic Resistance Testing Systems
North America is expected to lead the global antibiotic susceptibility testing market in terms of market value, accounting for nearly 28.6% share in the global market.
Growing adoption of antibiotic susceptibility testing in a medical laboratory, rising research and development activities for antibiotic resistance testing systems, and increased demand for antibiotic susceptibility testing to support empiric treatment is driving market growth in North America.
Most well-known corporations are based in the region. Key players have concentrated on expansion to broaden their network and capacities. These factors are driving market expansion across the continent.
Increased Prevalence of Infectious Diseases to Augment Demand for Antimicrobial Susceptible Test Products
The market in the USA. is likely to expand at a rapid pace over the forecast period, because of the rising prevalence of drug-resistant contagious diseases, a very well healthcare system, a favorable government environment, and rising R&D expenditure.
The excellent technical ability of market players has a significant impact on technological advancements of antimicrobial susceptible test products. Public health, as the top priority, has been demonstrated to have a favorable impact on public-private partnerships in the United States.
This is also expected to be used as a tool to help market players improve the pace of antimicrobial susceptible test product development.
Surge in Funding for Development of Antibiotic Sensitivity Testing
Growing concerns among people about their wellness and increasing use of over-the-counter antibiotics are driving market expansion in China. Rise in funding for the advancement of antibiotic sensitivity testing procedures is another important aspect for market expansion.
Increasing adoption of minimum inhibitory concentration in antibiotic sensitivity testing performed in a clinical lab, as well as increased antibiotic-resistant awareness activities, are driving market growth in China.
Manual Broth Microdilution System Most Preferred Attributed to Low Cost & Easy Handling Techniques
Susceptibility testing discs, MIC strips, and susceptibility testing plates are all manual broth microdilution systems. The demand for manual broth microdilution systems is being driven by an increase in antibiotic resistance, new product introductions, and the adoption of susceptibility testing discs.
Growing acceptance of the disc diffusion technique and improvements in susceptibility plates are driving the demand for manual broth microdilution systems. Moreover, manual products offer flexibility and cost savings through the use of technologies such as disc diffusion and gradient diffusion.
Due to an increase in demand for particular susceptibility testing systems to define the scope of targeted therapy, sales of manual broth microdilution system equipment will see healthy growth.
Hospitals to Remain Primary End User Due to Enhanced Health Coverage Plans
Antibiotic testing is performed in hospitals to a large extent with the latest technologies available, therefore hospitals are projected to dominate the market. Antibiotic susceptibility testing aids in the assessment of hospital-based treatment services.
The need for antibiotic susceptibility testing kits is increasing as a result of the recent shift toward individualized treatments. The large share of this segment is mainly attributed to the presence of a well-equipped facility and qualified professionals, the increase in hospital-acquired infectious diseases, and key companies' initiatives to sell antibiotic susceptibility testing products through hospitals.
Leading market players have upgraded their manufacturing facilities and are engaged in a variety of R&D activities. Regulatory approvals, high-tech products, introduction of new products, acquisitions, and collaborative partnerships with other companies are all priorities for key providers of antibiotic susceptibility testing systems.
For instance,
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2028 |
| Historical Data Available for | 2013 to 2021 |
| Market Analysis | Value in USD Million |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia & Pacific; Middle East & Africa (MEA) |
| Key Countries Covered |
USA, Canada, Mexico, Brazil, Mexico, Argentina, Germany, Italy, France, UK, Nordic, Spain, Japan, China, India, Malaysia, Thailand, Australia, GCC Countries, South Africa, Turkey |
| Key Market Segments Covered | Product, Application, End User, Region |
| Key Companies Profiled | BD; Danaher; Thermo Fisher Scientific; Bio-Rad; Creative Diagnostics; Accelerate Diagnostics; Alifax; Roche Diagnostics Limited; Merck Group; Synbiosis; MP Biomedicals; QuantaMatrix Inc.; Resistell AG |
| Pricing | Available upon Request |
Rising prevalence of testing in hospitals and diagnostics for providing appropriate therapies to patients is driving market growth.
Major companies supplying antibiotic susceptibility testing systems include BD, Danaher, Thermo Fisher Scientific, Bio-Rad, and Creative Diagnostics.
The global antibiotic susceptibility testing market is estimated to exhibit a CAGR of 5.2% during the forecast period (2022 to 2028).
North America accounts for 28.6% share of the global antibiotic susceptibility testing market.
The global market for antibiotic susceptibility testing is expected to reach a valuation of USD 4.05 Billion by 2028.
1. Executive Summary 2. Market Introduction 3. Global Market Opportunity Analysis 4. Global Economic Outlook 5. Key Inclusions 6. Market Background 7. North America Market Analysis 2013 to 2021 and Forecast 2022 to 2028 8. Latin America Market Analysis 2013 to 2021 and Forecast 2022 to 2028 9. Europe Market Analysis 2013 to 2021 and Forecast 2022 to 2028 10. APAC Market Analysis 2013 to 2021 and Forecast 2022 to 2028 11. Middle East and Africa Market Analysis 2013 to 2021 and Forecast 2022 to 2028 12. Forecast Factors: Relevance and Impact 13. Forecast Assumptions 14. Market Structure Analysis 15. Competition Analysis 15.1. BD 15.2. Thermo Fischer Scientific Inc. 15.3. bioMérieux SA 15.4. Bio-Rad Laboratories Inc. 15.5. Merck KGaA 15.6. Creative Diagnostics 15.7. Danaher Corporation 15.8. Accelerate Diagnostics, Inc. 16. Global Market Analysis 2013 to 2021 and Forecast 2022 to 2028 By Region 16.1. North America 16.2. Latin America 16.3. Europe 16.4. Asia-Pacific and China 16.5. Middle East and Africa 17. Global Market Analysis 2013 to 2021 and Forecast 2022 to 2028, By Product Type 17.1. Instruments 17.1.1. Automated Broth Microdilution Systems 17.1.2. Manual Broth Microdilution Systems 17.1.3. Semi-Automated Broth Microdilution Systems 17.2. Software & Services 17.2.1. Image Analysis Software 17.2.2. Installation Services 17.3. Kits & Reagents 18. Global Market Analysis 2013 to 2021 and Forecast 2022 to 2028, By End User 18.1. Diagnostic Laboratories 18.2. Hospitals 18.3. Research Laboratories 19. Global Market Analysis 2013 to 2021 and Forecast 2022 to 2028 20. Assumptions and Acronyms Used 21. Research Methodology
Healthcare
June 2023
REP-GB-12575
220 pages
Healthcare
June 2023
REP-GB-13025
273 pages
Explore Healthcare Insights
View Reports
Antibiotic Susceptibility Testing Market
